AKTX
Akari Therapeutics, Plc
NASDAQ · Healthcare · Biotechnology · GB
$11.77
+8.58%Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -0.38x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.22x
Liquidity & coverage
- Current ratio
- 0.60x
- Quick ratio
- 0.60x
- Cash ratio
- 0.55x
- Interest coverage
- -31.49x
- EBITDA / interest
- -32.35x
- Working capital
- -$5.6M
Cash & dividend
- FCF / debt
- -15.49x
- Cash flow / debt
- -15.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026